Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
羅德曼與仁信證券開始對Mural Oncology進行買入評級，並宣佈價格目標爲15美元。
Rodman & Renshaw analyst Tony Butler initiates coverage on Mural Oncology (NASDAQ:MURA) with a Buy rating and announces Price Target of $15.
Rodman＆Renshaw分析師Tony Butler開始對Mural Oncology（納斯達克股票代碼MURA）進行覆蓋，評級爲買入，並宣佈目標價格爲15美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。